Ironwood Pharmaceuticals (IRWD) Change in Acquisitions & Divestments (2010 - 2018)

Ironwood Pharmaceuticals has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $19.9 million in Q4 2018.

• Quarterly Change in Acquisitions & Divestments fell 28.48% year-over-year to $19.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $99.2 million (down 71.41% YoY) and the FY2018 annual result came in at $99.2 million, down 71.41% from the prior year.
• Change in Acquisitions & Divestments advanced to $19.9 million in Q4 2018 per IRWD's latest filing, from $16.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $212.0 million in Q3 2015 and troughed at $13.9 million in Q2 2018.
• A 5-year average of $65.0 million and a median of $48.6 million in 2018 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2015 and 2016: Change in Acquisitions & Divestments jumped 699.65% in 2015, then tumbled 89.8% in 2016.
• Over 5 years, Change in Acquisitions & Divestments stood at $52.5 million in 2014, then soared by 303.99% to $212.0 million in 2015, then plunged by 84.23% to $33.4 million in 2016, then decreased by 16.99% to $27.8 million in 2017, then retreated by 28.48% to $19.9 million in 2018.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $19.9 million, $16.8 million, and $13.9 million for Q4 2018, Q3 2018, and Q2 2018 respectively.